HRP980116A2 - Process for the preparation of 2-//(2-pyridinyl) methyl) sulfinyl/-1h-benzimidazoles and novel compounds of use for such purpose - Google Patents
Process for the preparation of 2-//(2-pyridinyl) methyl) sulfinyl/-1h-benzimidazoles and novel compounds of use for such purposeInfo
- Publication number
- HRP980116A2 HRP980116A2 HR0251/97A HRP980116A HRP980116A2 HR P980116 A2 HRP980116 A2 HR P980116A2 HR 0251/97 A HR0251/97 A HR 0251/97A HR P980116 A HRP980116 A HR P980116A HR P980116 A2 HRP980116 A2 HR P980116A2
- Authority
- HR
- Croatia
- Prior art keywords
- methyl
- compound
- pyridinyl
- och3
- benzimidazole
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims description 50
- 238000000034 method Methods 0.000 title claims description 27
- 230000008569 process Effects 0.000 title claims description 17
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 title claims description 12
- -1 2-pyridinyl Chemical group 0.000 title claims description 9
- 238000002360 preparation method Methods 0.000 title claims description 9
- 125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 title description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 36
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 30
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 17
- 230000009467 reduction Effects 0.000 claims description 14
- 229910052757 nitrogen Inorganic materials 0.000 claims description 13
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 11
- 239000002904 solvent Substances 0.000 claims description 11
- 239000003638 chemical reducing agent Substances 0.000 claims description 10
- QAWTYRYXDYHQNU-UHFFFAOYSA-N diazathiane Chemical compound NSN QAWTYRYXDYHQNU-UHFFFAOYSA-N 0.000 claims description 10
- 229910052794 bromium Inorganic materials 0.000 claims description 9
- 150000003839 salts Chemical class 0.000 claims description 8
- 239000001257 hydrogen Substances 0.000 claims description 7
- 229910052739 hydrogen Inorganic materials 0.000 claims description 7
- HKCNUIFWUYPDBM-UHFFFAOYSA-N 2-(pyridin-2-ylmethylsulfonyl)-1h-benzimidazole Chemical class N=1C2=CC=CC=C2NC=1S(=O)(=O)CC1=CC=CC=N1 HKCNUIFWUYPDBM-UHFFFAOYSA-N 0.000 claims description 6
- 230000001476 alcoholic effect Effects 0.000 claims description 6
- QLSLFFFIHPBPKZ-UHFFFAOYSA-N 4-morpholin-4-ylsulfanylmorpholine Chemical group C1COCCN1SN1CCOCC1 QLSLFFFIHPBPKZ-UHFFFAOYSA-N 0.000 claims description 5
- 125000000623 heterocyclic group Chemical group 0.000 claims description 5
- YNQDTNFXKPJZLM-UHFFFAOYSA-N 1-piperidin-1-ylsulfanylpiperidine Chemical compound C1CCCCN1SN1CCCCC1 YNQDTNFXKPJZLM-UHFFFAOYSA-N 0.000 claims description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical group N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 4
- 239000011707 mineral Substances 0.000 claims description 4
- 125000004786 difluoromethoxy group Chemical group [H]C(F)(F)O* 0.000 claims description 3
- 125000005843 halogen group Chemical group 0.000 claims description 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 3
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 claims description 2
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims description 2
- 125000004793 2,2,2-trifluoroethoxy group Chemical group FC(CO*)(F)F 0.000 claims description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 2
- 125000005842 heteroatom Chemical group 0.000 claims description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 2
- 229910052760 oxygen Inorganic materials 0.000 claims description 2
- 239000001301 oxygen Substances 0.000 claims description 2
- 229910052717 sulfur Inorganic materials 0.000 claims description 2
- 239000011593 sulfur Chemical group 0.000 claims description 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 24
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 24
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 17
- 238000002844 melting Methods 0.000 description 15
- 230000008018 melting Effects 0.000 description 15
- 239000000047 product Substances 0.000 description 15
- 239000002244 precipitate Substances 0.000 description 13
- MJIHNNLFOKEZEW-UHFFFAOYSA-N lansoprazole Chemical compound CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC=CC=C2N1 MJIHNNLFOKEZEW-UHFFFAOYSA-N 0.000 description 11
- 229960003174 lansoprazole Drugs 0.000 description 11
- 230000003647 oxidation Effects 0.000 description 11
- 238000007254 oxidation reaction Methods 0.000 description 11
- SUBDBMMJDZJVOS-UHFFFAOYSA-N 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole Chemical compound N=1C2=CC(OC)=CC=C2NC=1S(=O)CC1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-UHFFFAOYSA-N 0.000 description 10
- 229960000381 omeprazole Drugs 0.000 description 9
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- 239000000725 suspension Substances 0.000 description 8
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 7
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 6
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 6
- 239000008346 aqueous phase Substances 0.000 description 6
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- TVMJMCGRSSSSDJ-UHFFFAOYSA-N lansoprazole sulfone Chemical compound CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)(=O)C1=NC2=CC=CC=C2N1 TVMJMCGRSSSSDJ-UHFFFAOYSA-N 0.000 description 6
- OBGHBYDDJGHGNS-UHFFFAOYSA-N 2-[[3-methyl-1-oxido-4-(2,2,2-trifluoroethoxy)pyridin-1-ium-2-yl]methylsulfinyl]-1h-benzimidazole Chemical compound CC1=C(OCC(F)(F)F)C=C[N+]([O-])=C1CS(=O)C1=NC2=CC=CC=C2N1 OBGHBYDDJGHGNS-UHFFFAOYSA-N 0.000 description 5
- QZVDQETYNOBUPJ-UHFFFAOYSA-N 6-methoxy-2-[(4-methoxy-3,5-dimethyl-1-oxidopyridin-1-ium-2-yl)methylsulfinyl]-1h-benzimidazole Chemical compound N=1C2=CC(OC)=CC=C2NC=1S(=O)CC1=C(C)C(OC)=C(C)C=[N+]1[O-] QZVDQETYNOBUPJ-UHFFFAOYSA-N 0.000 description 5
- OTXQUGSUXRBUTC-UHFFFAOYSA-N butan-1-ol;toluene Chemical compound CCCCO.CC1=CC=CC=C1 OTXQUGSUXRBUTC-UHFFFAOYSA-N 0.000 description 5
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 5
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 5
- 239000012074 organic phase Substances 0.000 description 5
- 239000011541 reaction mixture Substances 0.000 description 5
- 150000003568 thioethers Chemical class 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 4
- IXEQEYRTSRFZEO-UHFFFAOYSA-N Omeprazole sulfone Chemical compound N1C2=CC(OC)=CC=C2N=C1S(=O)(=O)CC1=NC=C(C)C(OC)=C1C IXEQEYRTSRFZEO-UHFFFAOYSA-N 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- PODWXQQNRWNDGD-UHFFFAOYSA-L sodium thiosulfate pentahydrate Chemical compound O.O.O.O.O.[Na+].[Na+].[O-]S([S-])(=O)=O PODWXQQNRWNDGD-UHFFFAOYSA-L 0.000 description 4
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical class C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 description 4
- BTQQPSKHVXHHLC-UHFFFAOYSA-N 1-(2-amino-4-methoxyphenyl)-3-cyclohexylurea Chemical compound NC1=CC(OC)=CC=C1NC(=O)NC1CCCCC1 BTQQPSKHVXHHLC-UHFFFAOYSA-N 0.000 description 3
- ZBGMHRIYIGAEGJ-UHFFFAOYSA-N 6-methoxy-2-[(4-methoxy-3,5-dimethyl-1-oxidopyridin-1-ium-2-yl)methylsulfonyl]-1h-benzimidazole Chemical compound N1C2=CC(OC)=CC=C2N=C1S(=O)(=O)CC1=C(C)C(OC)=C(C)C=[N+]1[O-] ZBGMHRIYIGAEGJ-UHFFFAOYSA-N 0.000 description 3
- QGJOPFRUJISHPQ-UHFFFAOYSA-N Carbon disulfide Chemical compound S=C=S QGJOPFRUJISHPQ-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 3
- 150000001204 N-oxides Chemical class 0.000 description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- QOKLTUZRQYHMKW-UHFFFAOYSA-N n-cyclohexyl-5-methoxy-2-sulfanylidene-3h-benzimidazole-1-carboxamide Chemical compound S=C1NC2=CC(OC)=CC=C2N1C(=O)NC1CCCCC1 QOKLTUZRQYHMKW-UHFFFAOYSA-N 0.000 description 3
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- RQCPAMTYJRPELQ-UHFFFAOYSA-N 2-[[3-methyl-1-oxido-4-(2,2,2-trifluoroethoxy)pyridin-1-ium-2-yl]methylsulfonyl]-1h-benzimidazole Chemical compound CC1=C(OCC(F)(F)F)C=C[N+]([O-])=C1CS(=O)(=O)C1=NC2=CC=CC=C2N1 RQCPAMTYJRPELQ-UHFFFAOYSA-N 0.000 description 2
- CCHLMSUZHFPSFC-UHFFFAOYSA-N 2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfanyl]-1h-benzimidazole Chemical compound CC1=C(OCC(F)(F)F)C=CN=C1CSC1=NC2=CC=CC=C2N1 CCHLMSUZHFPSFC-UHFFFAOYSA-N 0.000 description 2
- JOXZAMWCPXYFKC-UHFFFAOYSA-N 4-methoxy-2,3,5-trimethyl-1-oxidopyridin-1-ium Chemical compound COC1=C(C)C=[N+]([O-])C(C)=C1C JOXZAMWCPXYFKC-UHFFFAOYSA-N 0.000 description 2
- QFMJFXFXQAFGBO-UHFFFAOYSA-N 4-methoxy-2-nitroaniline Chemical compound COC1=CC=C(N)C([N+]([O-])=O)=C1 QFMJFXFXQAFGBO-UHFFFAOYSA-N 0.000 description 2
- 238000001157 Fourier transform infrared spectrum Methods 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- KQWGXHWJMSMDJJ-UHFFFAOYSA-N cyclohexyl isocyanate Chemical compound O=C=NC1CCCCC1 KQWGXHWJMSMDJJ-UHFFFAOYSA-N 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 150000002431 hydrogen Chemical class 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- UEMUBQAKBBEBBG-UHFFFAOYSA-N n-cyclohexyl-2-sulfanylidene-3h-benzimidazole-1-carboxamide Chemical compound C12=CC=CC=C2NC(=S)N1C(=O)NC1CCCCC1 UEMUBQAKBBEBBG-UHFFFAOYSA-N 0.000 description 2
- 239000007800 oxidant agent Substances 0.000 description 2
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical group CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- ILVXOBCQQYKLDS-UHFFFAOYSA-N pyridine N-oxide Chemical class [O-][N+]1=CC=CC=C1 ILVXOBCQQYKLDS-UHFFFAOYSA-N 0.000 description 2
- 150000003222 pyridines Chemical class 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- YHMYGUUIMTVXNW-UHFFFAOYSA-N 1,3-dihydrobenzimidazole-2-thione Chemical compound C1=CC=C2NC(S)=NC2=C1 YHMYGUUIMTVXNW-UHFFFAOYSA-N 0.000 description 1
- FATJYTQFUNRCBK-UHFFFAOYSA-N 1-cyclohexyl-3-(4-methoxy-2-nitrophenyl)urea Chemical compound [O-][N+](=O)C1=CC(OC)=CC=C1NC(=O)NC1CCCCC1 FATJYTQFUNRCBK-UHFFFAOYSA-N 0.000 description 1
- FCJYMBZQIJDMMM-UHFFFAOYSA-N 1H-Benzimidazole, 5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfonyl]- Chemical compound COC1=CC=NC(CS(=O)(=O)C=2NC3=CC(OC(F)F)=CC=C3N=2)=C1OC FCJYMBZQIJDMMM-UHFFFAOYSA-N 0.000 description 1
- GMSURXZOJDDQEF-UHFFFAOYSA-N 2,3-dimethyl-1-oxido-4-(2,2,2-trifluoroethoxy)pyridin-1-ium Chemical compound CC1=C(C)[N+]([O-])=CC=C1OCC(F)(F)F GMSURXZOJDDQEF-UHFFFAOYSA-N 0.000 description 1
- HBDKFZNDMVLSHM-UHFFFAOYSA-N 2-(pyridin-2-ylmethylsulfinyl)-1h-benzimidazole Chemical compound N=1C2=CC=CC=C2NC=1S(=O)CC1=CC=CC=N1 HBDKFZNDMVLSHM-UHFFFAOYSA-N 0.000 description 1
- LGJKGASGASPHLH-UHFFFAOYSA-N 2-[[3-methyl-1-oxido-4-(2,2,2-trifluoroethoxy)pyridin-1-ium-2-yl]methylsulfanyl]-1h-benzimidazole Chemical compound CC1=C(OCC(F)(F)F)C=C[N+]([O-])=C1CSC1=NC2=CC=CC=C2N1 LGJKGASGASPHLH-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 125000000815 N-oxide group Chemical group 0.000 description 1
- XURCIPRUUASYLR-UHFFFAOYSA-N Omeprazole sulfide Chemical compound N=1C2=CC(OC)=CC=C2NC=1SCC1=NC=C(C)C(OC)=C1C XURCIPRUUASYLR-UHFFFAOYSA-N 0.000 description 1
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 1
- IQPSEEYGBUAQFF-UHFFFAOYSA-N Pantoprazole Chemical compound COC1=CC=NC(CS(=O)C=2NC3=CC=C(OC(F)F)C=C3N=2)=C1OC IQPSEEYGBUAQFF-UHFFFAOYSA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- SUWBCLBVUWODJK-UHFFFAOYSA-N chembl1366567 Chemical compound N1=C(C)C(C(=O)OCC)=C(O)C1(C(F)(F)F)NC1=NC2=CC=CC=C2S1 SUWBCLBVUWODJK-UHFFFAOYSA-N 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 230000027119 gastric acid secretion Effects 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000005580 one pot reaction Methods 0.000 description 1
- 229960005019 pantoprazole Drugs 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- XOVSRHHCHKUFKM-UHFFFAOYSA-N s-methylthiohydroxylamine Chemical compound CSN XOVSRHHCHKUFKM-UHFFFAOYSA-N 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 229950011585 timoprazole Drugs 0.000 description 1
- 150000003682 vanadium compounds Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK25197 | 1997-03-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP980116A2 true HRP980116A2 (en) | 1999-02-28 |
Family
ID=8091443
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR0251/97A HRP980116A2 (en) | 1997-03-07 | 1998-03-06 | Process for the preparation of 2-//(2-pyridinyl) methyl) sulfinyl/-1h-benzimidazoles and novel compounds of use for such purpose |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0968204A1 (fr) |
| AU (1) | AU5982198A (fr) |
| HR (1) | HRP980116A2 (fr) |
| NO (1) | NO994209L (fr) |
| WO (1) | WO1998040377A1 (fr) |
| ZA (1) | ZA981733B (fr) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE510643C2 (sv) * | 1997-06-27 | 1999-06-14 | Astra Ab | Termodynamiskt stabil omeprazol natrium form B |
| DK173431B1 (da) | 1998-03-20 | 2000-10-23 | Gea Farmaceutisk Fabrik As | Farmaceutisk formulering omfattende en 2-[[(2-pyridinyl)methyl]sulfinyl]benzimidazol med anti-ulcusaktivitet samt fremgangs |
| US6166213A (en) * | 1998-08-11 | 2000-12-26 | Merck & Co., Inc. | Omeprazole process and compositions thereof |
| US6191148B1 (en) | 1998-08-11 | 2001-02-20 | Merck & Co., Inc. | Omerazole process and compositions thereof |
| US7507829B2 (en) | 2002-12-19 | 2009-03-24 | Teva Pharmaceuticals Industries, Ltd | Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates |
| CA2528993A1 (fr) | 2003-06-10 | 2004-12-23 | Teva Pharmaceutical Industries Ltd. | Procede de preparation de benzimidazoles 2-[(pyridinyl)methyl]sulfinyle substitues et nouveau derives chlorures de pantoprazole |
| SE0400410D0 (sv) | 2004-02-20 | 2004-02-20 | Astrazeneca Ab | New compounds |
| DE602007005077D1 (de) | 2006-10-30 | 2010-04-15 | Dipharma Francis Srl | Verfahren zur Herstellung von Pyridinmethylsulphinylverbindungen |
| ES2343935B1 (es) * | 2008-12-29 | 2011-04-28 | Laboratorios Viñas S.A. | Intermedios utiles para la obtencion de 2-(2-piridinilmetilsulfinil)-1h-benzimidazoles y procedimientos correspondientes. |
| CN102964336B (zh) * | 2012-11-29 | 2014-08-06 | 寿光富康制药有限公司 | 质子泵抑制剂的精制方法及其n-氧化物的还原方法 |
| CN114163419A (zh) * | 2021-12-24 | 2022-03-11 | 辰欣药业股份有限公司 | 一种兰索拉唑的制备方法 |
| CN116444487A (zh) * | 2022-01-07 | 2023-07-18 | 重庆莱美药业股份有限公司 | 一种奥美拉唑的中间组合物及其制备方法和应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2026761A6 (es) * | 1990-10-31 | 1992-05-01 | Genesis Para La Investigacion | Procedimiento de obtencion del omeprazol. |
-
1998
- 1998-02-16 EP EP98902960A patent/EP0968204A1/fr not_active Ceased
- 1998-02-16 WO PCT/DK1998/000058 patent/WO1998040377A1/fr not_active Ceased
- 1998-02-16 AU AU59821/98A patent/AU5982198A/en not_active Abandoned
- 1998-03-02 ZA ZA981733A patent/ZA981733B/xx unknown
- 1998-03-06 HR HR0251/97A patent/HRP980116A2/hr not_active Application Discontinuation
-
1999
- 1999-08-31 NO NO994209A patent/NO994209L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0968204A1 (fr) | 2000-01-05 |
| AU5982198A (en) | 1998-09-29 |
| WO1998040377A1 (fr) | 1998-09-17 |
| ZA981733B (en) | 1998-09-04 |
| NO994209D0 (no) | 1999-08-31 |
| NO994209L (no) | 1999-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP980116A2 (en) | Process for the preparation of 2-//(2-pyridinyl) methyl) sulfinyl/-1h-benzimidazoles and novel compounds of use for such purpose | |
| KR101180530B1 (ko) | 제약방법 및 이 방법으로 조제된 화합물 | |
| HRP980115A2 (en) | Process for the preparation of 2-// (2-pyridinyl)-methyl/-sulfynyl/-1h-benzimidazoles and novel compounds of use for such purpose | |
| US5859030A (en) | Substituted arylalkylthioalkylthiopyridines for use in the control of helicobacter bacteria | |
| AU780314B2 (en) | Method for obtaining derivatives of (((pyridil substituted) methyl)thio)benzimidazol | |
| EP0262845A1 (fr) | Dérivés de l'azole à substituant hétérocyclique | |
| WO2001004109A1 (fr) | Procede de production de 2-(2-pyridinylmethylsulphinyle)-1h-benzimidazoles | |
| KR0142815B1 (ko) | 신규한 5-피롤릴-6-할로게노-2피리딜메틸설피닐벤즈이미다졸 유도체 | |
| JP2008514713A (ja) | ４，５−ジヒドロ−ピラゾロ［３，４−ｃ］ピリド−２−オン類の製造 | |
| IE852684L (en) | Benzimidazole derivatives | |
| JP2007521314A (ja) | プロトンポンプ阻害薬の異性体純粋なプロドラッグを製造するための方法 | |
| US6245913B1 (en) | Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole | |
| KR20030060901A (ko) | 팬토프라졸 및 그 중간체의 제조방법 | |
| Ahn et al. | A new synthetic process of lansoprazole | |
| WO2010134099A1 (fr) | Procédé de préparation dans un récipient unique d'oméprazole | |
| CA1292745C (fr) | Preparation de derives de substitution de la 8-thiotetrahydroquinoleine | |
| CA2553877C (fr) | Compose utile pour la synthese de s- et r-omeprazole et procede de preparation associe | |
| WO2007012650A1 (fr) | Inhibiteurs de pompe a protons isotopiquement substitues | |
| CA2457576C (fr) | Hydrates de 2-(2-pyridinyl)methylthio-1h-benzimidazoles eventuellement substitues et procedes de production de ceux-ci | |
| WO2009066309A2 (fr) | Procédé de préparation d'oméprazole | |
| CN102702173B (zh) | 一种制备质子泵抑制剂硫醚中间体的方法 | |
| US20070225500A1 (en) | Process for the Preparation of Pyridin-2-Ylmethylsulphinyl-1H-Benzimidazol Compounds | |
| JPH064625B2 (ja) | 置換イソキノリン誘導体および抗潰瘍剤 | |
| JP2011500664A (ja) | レニン阻害剤 | |
| MX2011005981A (es) | Nuevo proceso para preparar 4-[4-metil-5-(alquiltio c1-10/aril c5-10-alquilto c1-6)-4h-1,2,4-triazol-3-il]piridinas. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A1OB | Publication of a patent application | ||
| OBST | Application withdrawn |